{
    "title": "Drugmaker offers $1 rival to $750 pill that sparked outrage",
    "url": "https://www.dailymail.co.uk/wires/afp/article-3287046/Drugmaker-offers-1-rival-750-pill-sparked-outrage.html",
    "date": "2015-10-23",
    "keywords": [
        "drug",
        "price",
        "daraprim",
        "imprimis",
        "company",
        "drugmaker",
        "rival",
        "outrage",
        "october",
        "percent",
        "hike",
        "pyrimethamine",
        "capsule",
        "outcry",
        "debate",
        "europe",
        "use",
        "executive",
        "insurance",
        "response",
        "pill",
        "afp",
        "gmt",
        "email",
        "california",
        "specialty",
        "prescription",
        "month",
        "statesimprimis",
        "combination",
        "leucovorin",
        "lowcost",
        "alternative",
        "infectionthe",
        "san",
        "bottle",
        "tick",
        "huguen",
        "toxoplasmosis",
        "infection",
        "hivaidsleucovorin",
        "bone",
        "marrow",
        "custom",
        "compound",
        "ingredient",
        "administration",
        "treatment",
        "market",
        "august",
        "impax",
        "laboratoriesin",
        "september",
        "tablet",
        "move",
        "nerve",
        "founder",
        "martin",
        "hedge",
        "fund",
        "manager",
        "man",
        "america",
        "video",
        "cost",
        "pillthe",
        "pharmacy",
        "benefit",
        "mark",
        "baum",
        "statementthis",
        "time",
        "level",
        "program",
        "case",
        "shkreli",
        "anger",
        "query",
        "friday",
        "closing",
        "nasdaq"
    ],
    "category": [
        "wires",
        "afp"
    ]
}